臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"yang c h"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 631-655 of 1273 (51 Page(s) Totally)
<< < 21 22 23 24 25 26 27 28 29 30 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2020-09-30T03:23:01Z	Cytomegalovirus retinitis and immune recovery uveitis in AIDS patients treated with highly active antiretroviral therapy in Taiwanese	Chang S.-C.; CHIEN-CHING HUNG; Sheng W.-H.; Chen M.-Y.; Lin Y.-C.; Yang C.-H.; Lin C.-P.; Yang C.-M.; Chen M.-S.
臺大學術典藏	2020-09-30T03:23:00Z	Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984-2005	Yang S.-Y.; Yang C.-H.; Huang Y.-F.; Hsiao C.-F.; Yeh Y.-L.; Liou H.-R.; CHIEN-CHING HUNG
臺大學術典藏	2020-09-30T03:22:59Z	Seroprevalence of chronic hepatitis B virus infection among Taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination	Sun H.-Y.;Ko W.-C.;Tsai J.-J.;Lee H.-C.;Liu C.-E.;Wong W.-W.;Su S.-C.;Ho M.-W.;Cheng S.-H.;Yang C.-H.;Lin Y.-H.;Miao W.-J.;Sheng W.-H.;Chien-Ching Hung; Sun H.-Y.; Ko W.-C.; Tsai J.-J.; Lee H.-C.; Liu C.-E.; Wong W.-W.; Su S.-C.; Ho M.-W.; Cheng S.-H.; Yang C.-H.; Lin Y.-H.; Miao W.-J.; Sheng W.-H.; CHIEN-CHING HUNG
臺大學術典藏	2020-09-23T07:36:16Z	Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma	Huang C.-T.; Yen R.-F.; MEI-FANG CHENG; Hsu Y.-C.; Wei P.-F.; Tsai Y.-J.; Tsai M.-F.; Shih J.-Y.; Yang C.-H.; Yang P.-C.
臺大學術典藏	2020-09-23T06:22:34Z	Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma	Huang C.-T.; RUOH-FANG YEN; Cheng M.-F.; Hsu Y.-C.; Wei P.-F.; Tsai Y.-J.; Tsai M.-F.; Shih J.-Y.; Yang C.-H.; Yang P.-C.
臺大學術典藏	2020-08-13T06:34:06Z	Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer	JIN-YUAN SHIH; Gow C.-H.; Yu C.-J.; Yang C.-H.; Chang Y.-L.; Tsai M.-F.; Hsu Y.-C.; Chen K.-Y.; Su W.-P.; Yang P.-C.
臺大學術典藏	2020-08-13T06:34:06Z	Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status	Su W.-P.; Yang C.-H.; Yu C.-J.; JIN-YUAN SHIH; Hsu C.; Yang P.-C.; Su W.-P.;Yang C.-H.;Yu C.-J.;Jin-Yuan Shih;Hsu C.;Yang P.-C.
臺大學術典藏	2020-08-13T06:34:05Z	Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer	Lin C.-P.; Su W.-P.; Gow C.-H.; Hsu C.; Chang G.-C.; Yang P.-C.; Yu C.-J.; Yang T.-Y.; Yang C.-H.; JIN-YUAN SHIH; Chen K.-C.
臺大學術典藏	2020-08-13T06:34:03Z	Radiotherapy in lung adenocarcinoma with brain metastases: Effects of activating epidermal growth factor receptor mutations on clinical response	JIN-YUAN SHIH; Chang Y.-C.; Yu C.-J.; Yang C.-H.; Yang P.-C.; Kuo S.-H.; Chiu Y.-H.; Gow C.-H.; Chien C.-R.; Chang Y.-L.
臺大學術典藏	2020-08-13T06:34:03Z	MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib	Bean J.; Brennan C.; JIN-YUAN SHIH; Riely G.; Viale A.; Wang L.; Chitale D.; Motoi N.; Szoke J.; Broderick S.; Balak M.; Chang W.-C.; Yu C.-J.; Gazdar A.; Pass H.; Rusch V.; Gerald W.; Huang S.-F.; Yang P.-C.; Miller V.; Ladanyi M.; Yang C.-H.; Pao W.; Bean J.;Brennan C.;Jin-Yuan Shih;Riely G.;Viale A.;Wang L.;Chitale D.;Motoi N.;Szoke J.;Broderick S.;Balak M.;Chang W.-C.;Yu C.-J.;Gazdar A.;Pass H.;Rusch V.;Gerald W.;Huang S.-F.;Yang P.-C.;Miller V.;Ladanyi M.;Yang C.-H.;Pao W.
臺大學術典藏	2020-08-13T06:34:01Z	Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy	Yang P.-C.; Pao W.; Cheng A.-L.; Yang C.-H.; Yu C.-J.; JIN-YUAN SHIH; Chang Y.-C.; Hu F.-C.; Tsai M.-C.; Chen K.-Y.; Lin Z.-Z.; Huang C.-J.; Shun C.-T.; Huang C.-L.; Bean J.
臺大學術典藏	2020-08-13T06:34:00Z	First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer	Wu J.-Y.; Yu C.-J.; Yang P.-C.; JIN-YUAN SHIH; Wei P.-F.; Hsu Y.-C.; Chang Y.-C.; Gow C.-H.; Yang C.-H.; Wu S.-G.; Chiu Y.-H.
臺大學術典藏	2020-08-13T06:34:00Z	Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma	Wu S.-G.; Gow C.-H.; Yu C.-J.; Chang Y.-L.; Yang C.-H.; Hsu Y.-C.; JIN-YUAN SHIH; Lee Y.-C.; Yang P.-C.
臺大學術典藏	2020-08-13T06:33:59Z	Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial	Yang C.-H.; Yang P.-C.; Huang T.-C.; Lin C.-C.; Yu C.-J.; Hsu C.; Kuo S.-H.; Hu F.-C.; Cheng A.-L.; JIN-YUAN SHIH
臺大學術典藏	2020-08-13T06:33:59Z	EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment	JIN-YUAN SHIH; Lin Z.-Z.; Yu C.-J.; Cheng A.-L.; Yang P.-C.; Chen K.-Y.; Huang C.-L.; Yang C.-H.; Yeh K.-H.; Hu F.-C.
臺大學術典藏	2020-08-13T06:33:59Z	Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer	Gow C.-H.; Chang Y.-L.; Hsu Y.-C.; Tsai M.-F.; Wu C.-T.; Yu C.-J.; Yang C.-H.; Lee Y.-C.; Yang P.-C.; JIN-YUAN SHIH
臺大學術典藏	2020-08-13T06:33:58Z	Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer	JIN-YUAN SHIH; Yang C.-H.; Chen K.-Y.; Ho C.-C.; Yu C.-J.; Yang P.-C.; Wu J.-Y.; Wu J.-Y.;Jin-Yuan Shih;Yang C.-H.;Chen K.-Y.;Ho C.-C.;Yu C.-J.;Yang P.-C.
臺大學術典藏	2020-08-13T06:33:58Z	Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptors	Mok T.; Yang C.-H.; Leung L.; Lam K.C.; Lin C.-C.; Hsu H.-H.; Sun C.-T.; JIN-YUAN SHIH; Lin Z.-Z.; Yu C.-J.; Chen G.G.; Hsin M.K.Y.; Lin C.-C.;Hsu H.-H.;Sun C.-T.;Jin-Yuan Shih;Lin Z.-Z.;Yu C.-J.;Chen G.G.;Hsin M.K.Y.;Lam K.C.;Leung L.;Yang C.-H.;Mok T.
臺大學術典藏	2020-08-13T06:33:57Z	Pemetrexed for heavily pretreated patients with advanced non-small cell lung cancer	Lee J.-H.;Yu C.-J.;Chen K.-Y.;Jin-Yuan Shih;Lin Y.-L.;Yang C.-H.; Lee J.-H.; Yu C.-J.; Chen K.-Y.; JIN-YUAN SHIH; Lin Y.-L.; Yang C.-H.
臺大學術典藏	2020-08-13T06:33:57Z	Use of cetuximab after failure of gefitinib in patients with advanced non-small-cell lung cancer	Wu J.-Y.; Yang C.-H.; Hsu Y.-C.; Yu C.-J.; Chang S.-H.; JIN-YUAN SHIH; Yang P.-C.; Wu J.-Y.;Yang C.-H.;Hsu Y.-C.;Yu C.-J.;Chang S.-H.;Jin-Yuan Shih;Yang P.-C.
臺大學術典藏	2020-08-13T06:33:57Z	Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma	Yen R.-F.; Huang C.-T.; Huang C.-T.;Yen R.-F.;Cheng M.-F.;Hsu Y.-C.;Wei P.-F.;Tsai Y.-J.;Tsai M.-F.;Jin-Yuan Shih;Yang C.-H.;Yang P.-C.; Cheng M.-F.; Hsu Y.-C.; Wei P.-F.; Tsai Y.-J.; Tsai M.-F.; JIN-YUAN SHIH; Yang C.-H.; Yang P.-C.
臺大學術典藏	2020-08-13T06:33:54Z	Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor	Lin S.-B.; Wu C.-P.; JIN-YUAN SHIH; Yang P.-C.; Lan C.-C.; Yang C.-H.; Yu Y.-L.; Yu S.-L.; Huang C.-P.; Chang T.-H.; Tsai M.-F.; Su K.-Y.; Wu S.-G.
臺大學術典藏	2020-08-13T06:33:53Z	Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations	Chang Y.-L.; JIN-YUAN SHIH; Yang P.-C.; Hsu Y.-C.; Lee J.-H.; Wu S.-G.;Yang C.-H.;Yu C.-J.;Lee J.-H.;Hsu Y.-C.;Chang Y.-L.;Jin-Yuan Shih;Yang P.-C.; Wu S.-G.; Yang C.-H.; Yu C.-J.
臺大學術典藏	2020-08-13T06:33:53Z	Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations	Wu J.-Y.; Wu J.-Y.;Jin-Yuan Shih;Chen K.-Y.;Yang C.-H.;Yu C.-J.;Yang P.-C.; Yang P.-C.; JIN-YUAN SHIH; Chen K.-Y.; Yang C.-H.; Yu C.-J.
臺大學術典藏	2020-08-13T06:33:53Z	Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations	Wu J.-Y.; Wu S.-G.; Yang C.-H.; Chang Y.-L.; Chang Y.-C.; Hsu Y.-C.; JIN-YUAN SHIH; Yang P.-C.

Showing items 631-655 of 1273 (51 Page(s) Totally)
<< < 21 22 23 24 25 26 27 28 29 30 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 2856565
	???header.visitor??? : 53423440 ???header.onlineuser??? : 659 ???header.sponsordeclaration???